Title: Malaria pathogenesis
1Malaria pathogenesis
2Parasite 'turns women into sex kittens'By Jane
Bunce, December 26, 2006 0527pm, Article from
AAP
A COMMON parasite can increase a women's
attractiveness to the opposite sex but also make
men more stupid, an Australian researcher
says. About 40 per cent of the world's
population is infected with Toxoplasma gondii,
including about eight million Australians. Until
recently it was thought to be an insignificant
disease in healthy people, Sydney University of
Technology infectious disease researcher Nicky
Boulter said, but new research has revealed its
mind-altering properties. "Interestingly, the
effect of infection is different between men and
women,'' Dr Boulter writes in the latest issue of
Australasian Science magazine. "Infected men
have lower IQs, achieve a lower level of
education and have shorter attention spans. They
are also more likely to break rules and take
risks, be more independent, more anti-social,
suspicious, jealous and morose, and are deemed
less attractive to women. "On the other hand,
infected women tend to be more outgoing,
friendly, more promiscuous, and are considered
more attractive to men compared with non-infected
controls. "In short, it can make men behave like
alley cats and women behave like sex kittens''.
(http//www.news.com.au/story/0,10117,20975555-2
9277,00.html)
3Apicomplexan invasion
- Active, parasite driven process
- Depends on parasite actin/myosin motility
(conveyor belt model) - Involves secretion of micronemes (attachment,
motility), rhoptries (PV MJ formation) and
dense granules (makes PV into a suitable home) - Sets up a parasitophorous vacuole which initially
is derived from the host cell cell-membrane - A moving junction is formed which screens out
host membrane proteins from the PV, the PV is
fusion incompetent and the parasite protected
4Two great movie clips summarizing the malaria
life cycle
- Development in the human
- http//www.hhmi.org/biointeractive/disease/malaria
_anim/malaria-human.html - Development in the mosquito
- http//www.youtube.com/watch?v7sHB56AjHQ8feature
related - (make sure to watch these before the next exam)
5Malaria II
- Malaria the disease
- Pathogenesis of severe falciparum malaria
- Drugs used to treat malaria and the development
of drug resistance
6Malaria the disease
- Human malaria is primarily a blood disease,
however it causes pathology in a variety of
organs tissues - All disease is due to the parasites development
within the red blood cell (merozoite,
trophozoite, schizont). - Other stages are important for transmission but
they do not contribute to pathogenesis
7Malaria the disease
- 9-14 day incubation period
- Fever, chills, headache, back and joint pain
- Gastrointestinal symptoms (nausea, vomiting, etc.)
8Malaria the disease
9Malaria the disease
- Malaria tertiana 48h between fevers (P. vivax
and ovale) - Malaria quartana 72h between fevers (P.
malariae) - Malaria tropica irregular high fever (P.
falciparum)
10Malaria the disease
- Symptoms intensify
- Irregular high fever
- Anxiety, delirium and other mental problems
- Sweating, increased pulse rate, severe exhaustion
- Worsening GI symptoms
- Enlarged spleen and liver
11Malaria the disease
3 Severe manifestations
Cerebral malaria
Severe anemia
Renal failure
Irritability, loss of reflexes, neurological
symptoms similar to menigitis, coma 20 fatality
Progressive severe drop of hematocrit, poor
oxygen Supply for organs and tissues
Dwindling urine, high urea Level in serum,
hyperventilation Coma, poor prognosis
12Malaria the disease
WHO-TDR
13Pathogenesis of malaria
- In highly endemic areas high mortality among
children due to severe anemia, children who
survive beyond the first years show decreasing
parasitemia and disease (this immunity is not
sterile and depends on constant exposure) - In areas with less infection pressure malaria is
an epidemic disease with varying intensity.
Adults and children are equally susceptible and
death in adults is mostly due to cerebral malaria
14Pathogenesis of malaria
Age
15Pathogenesis of cerebral malaria
- Cerebral malaria is characterized by multiple
brain hemorrhages (vessel rupture and bleeding) - Excessive serum and tissue levels of TNFa and
INFg (two important immune hormones driving
inflammation) are associated with severe malaria - Some researchers believe this inflammation is the
main cause for pathology (remember the immunology
introduction an overshooting immune response
against a chronic pathogen that can not be
cleared can cause severe disease)
16Sequestration cytoadherence
- The second model suggests sequestration to be the
main culprit - In P. falciparum infections only early stages
(rings) are found in the peripheral blood - Trophozoites and schizonts are sequestered to the
post-capilary venules by attachment to the
endothelium
Ring stages
17Pathogenesis of falciparum malaria
- Parasite infected RBC become sticky and adhere
to endothelial cells - This phenomenon takes about 10-12 hours to
develop after parasite invasion - Under high flow (here modeled using a
microfluidic device) this first results in
rolling and then in attachment - (movie courtesy of Dr. Pradip Rathod University
of Washington)
18Pathogenesis of falciparum malaria
- Cytoadherence seems to be the main culprit for
pathogenesis - Infected RBCs will adhere to the endothelium as
well as to each other and cause clogging and
hemorhaging - Note that high cytokine levels induce expression
of endothelial adhesins -- inflammation makes the
endothelia stickier - Adherence and inflammation reinforce each other
in an unholy circle causing pathology
19Knobs and cytoadherence
- Cytoadhrence correlates with the presence of
knobs (left column) on the surface of the
infected RBC - The right column shows a RBC infected with a
knob-less strain which does not cause cerebral
malaria - Knobs are made up of parasite derived proteins
knobs
knob-less
20Knobs and cytoadherence
- PfEMP1 (P. falciparum erythrocyte membrane
protein) is found in knobs and is responsible for
cytoadherence and rosetting - PfEMP1 is a large membrane protein anchored in
the RBC membrane with the bulk extending into the
blood stream - Various domains of PfEMP1 have been shown to bind
to ligands on the endothelia of the vasculature
and the placenta - PfEMP1 is an important pathogenesis factor
21Knobs and cytoadherence
22Knobs and cytoadherence
- The parasite exports PfEMP1 and other proteins
(this picture is showing Knob associated protein)
into the RBC and its surface to form knobs - F in early rings protein is in the parasite and
the parasitophorous vacuole, G,H in trophozoites
it is found first within the RBC cytoplasm and
then at the RBC membrane (I).
23Knobs and cytoadherence
- How precisely the parasite transports proteins
through the RBC is still under study - However it is clear that the parasite has not
only to provide the cargo but also the transport
machinery as the RBC has reduced its capability
for membrane transport and secretion - All these proteins are initially secreted by the
parasite into the parasitophorous vacuole - A recently discovered gatekeeper in the vacuole
membrane appears to shuttle proteins across (PTEX
Plasmodium translocon of exported proteins) - Maurers clefts (parasite induced membranous
structures in the RBC) appear to be an important
bridgehead acting in the sorting and trafficking
of exported proteins
Reiff Striepen, Nature 459918
24Immunity to malaria
- There is no sterile immunity to malaria
- Patients produce strong antibody responses to
PfEMP1 which is exposed to the immune system on
the surface of the infected RBC. - Why is the immunity to malaria relatively weak?
- PfEMP1 is encoded by a large multigene family
(VAR genes) and parasites switch to new variants
(antigenic variation again) - The parasite genome encodes 60 VAR genes, only
one is expressed at a time (allelic exclusion)
25Immunity to malaria
- Successful vaccination in humans has been
achieved with large doses of irradiated
sporozoites, however that is likely not practical - Many approaches have been and are explored to
stimulate immunity against sporozoites (infection
blocking), merozoites (disease blocking) or
gametocytes (transmission blocking) - None has yielded a satisfactory and safe human
vaccine yet - The most promising new strategies use genetic
manipulation to engineer attenuated parasites
strains (parasites that enter cells and induce
immunity yet fail to develop fully and cause
disease) - For now, control depends heavily on drug therapy
26Chinchona the source of quinine
- Peruvian Indians appear to have been the first to
know about the medicinal effects of quinine, they
chewed Chinchona bark while working in the mines
as forced laborers for the Spanish - Jesuits brought the bark back to Europe to treat
febrile diseases - In the early 1600s the bark was used to treat the
fever of the Countess of Chinchon and became well
known as Jesuits powder or Peruvian bark - Initial preparations were often quite variable in
the amount of active ingredient resulting in
varying effects
27Chichona the source of quinine
- High demand had brought the Chinchona tree almost
to extinction in the wild - Charles Ledger a trader in Peru send out Manuel
Incra Macrami to collect seeds from a stand of
special trees they had found earlier - After three years Manuel came back with 15 kg of
seeds which they sold for 100 guilders to the
Dutch consul as the British were not interested - C. ledgeriana formed the basis of a very
profitable Dutch quinine monopoly which lasted
until World War II
28Chloroquine the wonder drug
- Chloroquine, a synthetic quinine analog developed
by German and American chemists during WWII, was
a very potent drug that was cheap to make,
stable, and had no serious side effects - Chloroquine was a major component of the 60/70s
malaria eradication campaign - None of the drugs developed since come close to
chloroquine
29Chloroquine the wonder drug
- During its development within the RBC the malaria
parasite ingests the cytoplasma of its host - Note that in this schematic (and in real
micrographs) the red color of the blood cell gets
considerably lighter -- at the same time malaria
pigment accumulates - The parasite digests large ammounts of hemoglobin
to cover part of its amino acid needs
30Chloroquine the wonder drug
- RBC cytoplasm is taken up by endocytosis
- The endocytotic vesicles fuse with the food
vacuole (a homolog of the secondary lysosome)
were hemoglobin digestion occurs - Digestion frees large ammounts of heme
- Heme is toxic to the parasite and is neutralized
by polymerization into the malaria pigment or
hemozoin - Chloroquine accumulates in the food vacuole (its
a weak base and like all lysosomes the FV is an
acidic compartment) - Chloroquine is thought to interfere with the
polymerization and detoxification of heme
31Resistance to chloroquine
1965
1960
1978
1989
http//www.tigr.org/tdb/edb/pfdb/CQR.html
32Mechanisms of drug resistance
33Mechanisms of drug resistance
- Changes in target enzyme (e.g. decreased affinity
to drug) - Overexpression of target (amplification)
- Decreased activation of drug
- Changes in accessibility (less import, or more
export of drug)
34Resistance to chloroquine
- Genetic studies have shown that resistance is
linked to the transporter protein PfCRT - Studies using parasite cultures suggests that a
series of point mutations in PfCRT are
responsible for resistance - This putative transporter localizes to the
membrane of the food vacuole - Large field studies have found strong association
of these mutations with chloroquine resistance - It is now thought that the natural role of
PfCRT is to export small peptides from the food
vacuole
PfCRT, resistance mutations highlighted
35Antifolates as malaria drugs
- The synthesis of certain building blocks of DNA
requires reduced folate (more specifically the
syntheisis of dTMP) - No reduced folate -- no DNA
- The malaria drug Fansidar uses a drug combination
to hit the same target pathway twice - Combinations that are more effective than the sum
of their individual activities are called
synergistic
36Antifolates as malaria drugs
Parasite
GTP
Folate synthesis
Dihydrofolate
Folate recharging
Tetrahydrofolate
37Antifolates as malaria drugs
Parasite
Human
GTP
Folate synthesis
Dihydrofolate
Dihydrofolate
Nucleotide synthesis
Folate recharging
Tetrahydrofolate
Tetrahydrofolate
38Antifolates as malaria drugs
Parasite
Human
GTP
Folate synthesis
Sulfonamide
Dihydrofolate
Dihydrofolate
Nucleotide synthesis
Folate recharging
Tetrahydrofolate
Tetrahydrofolate
39Antifolates as malaria drugs
Human
Dihydrofolate
Nucleotide synthesis
Tetrahydrofolate
40Antifolates as malaria drugs
- First strike Folate synthesis. We cant make
folate and take it up with food as a vitamin. The
parasite makes it and is therefore susceptible to
sulfonamides which block synthesis - Second strike After each use dihydrofolate has
to be reduced again (think of it as recharging).
The enzyme which does this (dihydrofolate
reductase) is different in human and parasite - The drug pyrimethamine inhibits parasite DHFR but
not human DHFR - Fansidar combines pyrimethamine with sulfadoxine
- A very similar drug combination is used to treat
toxoplasmosis
41Antifolate resistance developed very fast
42Combinations of Artemisinin and other
antimalarials are promising
- Extracts of Artemisia annua (sweet wormwood) have
long been used in traditional Chinese medicine to
treat fever - Chinese investigators extracted the active
ingredients and showed that they and there
chemical modifications are powerful antimalarials - However monotherapy results in high level of
recrudescence - Combining Artemisinin with other drugs have been
very successful especially for severe malaria - Artemisinin acts very fast which helps to reduce
mortality and get patients out of their coma
quickly
43Summary
- Severe forms of malaria include severe anemia in
kids, and cerebral and renal malaria in adults - Severe pathogenesis is related to adherence of
infected RBC to entothelia - Adherence is mediate by knobs in the RBC surface
made up by parasite proteins (PFEMP1) - PFEMP1 undergoes antigenic variation
- Chloroquine resistance has been a public health
catastrophe - Chloroquine accumulates in the food vacuole and
prevents heme polymerization, resistance is
linked to mutations in a transport protein in the
food vacuole membrane